MEDIA

Media Inquiries

Ghopkins@OncoSec.com

858-210-7334

Press Releases

VIEW ALL PRESS RELEASES

Video Feed

OncoSec at 2020 BIO CEO Panel

✕

IAD Reel

✕

Tumor Immunogenicity

✕

IAD Robert Andtbacka, M.D.

✕

TAVO Demonstration with Dr Algazi

✕

3D MOA Animation video

✕

Social Media

Twitter Feed

OncoSec Medical@OncoSec·
2 Apr

In @PharmaVOICE's latest Woman of the Week podcast, @tgrom sat down with our Chief Clinical Development Officer, Kellie Malloy, to discuss her expertise in the CRO industry and our clinical programs for #cancers with limited treatment options. Listen here: https://www.pharmavoice.com/wow-podcasts/wow-kellie-malloy-foerter/

OncoSec Medical@OncoSec·
2 Apr

Our visceral lesion applicator (VLA) platform has the potential to change the treatment paradigm for #cancer by delivering potent immunotherapy directly to tumors and potentially increasing responses to existing therapies. Learn about our VLA technology: https://oncosec.com/tavo/

pharmavoice@PharmaVOICE·
1 Apr

In today’s #WoW podcast, Kellie Malloy Foerter, Chief Clinical Development Officer @OncoSec Medical discusses ongoing clinical studies in breast cancer treatment, hopes for intratumoral therapy, and leadership skills. https://www.pharmavoice.com/wow-podcasts/wow-kellie-malloy-foerter/

pharmavoice@PharmaVOICE·
31 Mar

After two decades working in the #CRO industry, tomorrow’s #WoW podcast guest, Kellie Malloy Foerter, Chief Clinical Development Officer, @OncoSec Medical, is tracking exciting new ways to evaluate potential cancer treatments. Listen in tomorrow! https://www.pharmavoice.com/wow-podcasts/

Featured Articles

Natural Gene Therapy

Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy

PHARMAVOICE

The intersection of physics and biology

INTRA TUMORAL DELIVERY

Arming the Immune System; Turning Cold Tumors Hot